MedTrace Logo

Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults

NCT06244147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-06

No results posted yet for this study

Summary

The primary objective is to evaluate the clinical safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months. The secondary objectives are to evaluate the laboratory safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months and to evaluate the efficacy of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months.

Conditions

Interventions

DIETARY_SUPPLEMENT

KSM-66 Ashwagandha Root Extract

Participants will take KSM-66 Ashwagandha root extract 300mg twice a day for the duration of the study.

Sponsors & Collaborators

  • SF Research Institute, Inc.

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2025-10-15
Completion
2025-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06244147 on ClinicalTrials.gov